Research / FCUV / Fundamental state Inspectable configuration
State dimensions Filing 0001683168-20-001607 General Corporate
Capex intensity 44th Own-history percentile · N=9
Evidence method Level · gp.fundamentals.capex_revenue_ratio
0.00% · OPTIONAL · VALID
Operating cash generation 33th Own-history percentile · N=9
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
-209.13% · OPTIONAL · VALID
Revenue growth 50th Own-history percentile · N=8
Evidence method Yoy · gp.fundamentals.revenue
27.96% · CORE · VALID
Inventory pressure 42th Own-history percentile · N=12
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
24.85% · OPTIONAL · VALID
Gross margin 0th Own-history percentile · N=12
Evidence method Level · gp.fundamentals.gross_margin
-8.84% · CORE · VALID
Operating margin 25th Own-history percentile · N=12
Evidence method Level · gp.fundamentals.operating_margin
-312.38% · CORE · VALID
R&D intensity 25th Own-history percentile · N=12
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
22.66% · OPTIONAL · VALID
SBC intensity RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
3.86% · OPTIONAL · NOT_ENOUGH_HISTORY
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 38 states Self-history eligible
Sep 30, 2021 7/7 normalized Level 3 Dec 31, 2021 7/7 normalized Level 3 Mar 31, 2022 7/7 normalized Level 3 Jun 30, 2022 7/7 normalized Level 3 Sep 30, 2022 8/8 normalized Level 3 Dec 31, 2022 8/8 normalized Level 3 Mar 31, 2023 8/8 normalized Level 3 Jun 30, 2023 7/7 normalized Level 3 Sep 30, 2023 7/7 normalized Level 3 Dec 31, 2023 7/7 normalized Level 3 Mar 31, 2024 7/7 normalized Level 3 Jun 30, 2024 7/7 normalized Level 3 Sep 30, 2024 7/7 normalized Level 3 Dec 31, 2024 7/7 normalized Level 3 Mar 31, 2025 7/7 normalized Level 3 Jun 30, 2025 7/7 normalized Level 3 Sep 30, 2025 7/7 normalized Level 3 Dec 31, 2025 7/7 normalized Level 3 Mar 31, 2026 6/6 normalized Level 3 Jun 30, 2026 5/6 normalized Level 4 Period transition
What moved in the state? Capex Intensity Decreased
Previous 0.76%
Current 0.00%
Delta -0.76% Cash Generation Decreased
Previous -116.26%
Current -209.13%
Delta -92.88% Growth Decreased
Previous 373.95%
Current 27.96%
Delta -345.99% Inventory Pressure Increased
Previous 4.31%
Current 24.85%
Delta 20.54% Margin Decreased
Previous 8.10%
Current -8.84%
Delta -16.94% Profitability Decreased
Previous -228.05%
Current -312.38%
Delta -84.33% R And D Intensity Increased
Previous 17.48%
Current 22.66%
Delta 5.19% Sbc Intensity Decreased
Previous 5.15%
Current 3.86%
Delta -1.29% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.